XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2021
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

    

Three Months Ended March 31, 

    

Nine Months Ended March 31, 

2020

    

2021

    

2020

    

2021

Cost of goods sold

$

189

$

199

$

517

$

571

Selling, general and administrative

 

5,520

7,223

 

17,153

 

18,391

Research and development

 

128

143

 

427

 

424

Stock-based compensation expense

$

5,837

$

7,565

$

18,097

$

19,386

Summary of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2020

 

326,304

 

$

44.41

 

Granted

 

22,171

82.17

Exercised

 

(87,235)

34.44

Expired or forfeited

 

(2,710)

78.71

Outstanding at March 31, 2021

 

258,530

50.65

2.8 years

$

11,818

Exercisable at March 31, 2021

222,512

45.03

 

1.8 years

11,387

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2020

 

423,590

$

88.68

Granted

 

337,778

80.32

Vested

 

(310,939)

86.20

Forfeited

 

(8,244)

84.47

Nonvested at March 31, 2021

 

442,185

$

84.12